Merrimack Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.99%)
Merrimack Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-22NW Fund, LP(0%),22NW, LP(0%), etc.
Merrimack Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.2%)
Merrimack Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Newtyn Management, LLC(13.1%),Noah G. Levy(13.1%), etc.
Merrimack Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Andersen Eric
Merrimack Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Western Standard, LLC(15.5%),Eric D. Andersen(15.5%), etc.
Merrimack Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Andersen Eric
Merrimack Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Andersen Eric
Merrimack Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Andersen Eric
Merrimack Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Andersen Eric
Merrimack Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Andersen Eric
Merrimack Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer CROCKER GARY L
Merrimack Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Western Standard, LLC(13.9%),Eric D. Andersen(13.9%), etc.
Merrimack Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Andersen Eric
Merrimack Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Radeljevic Ana
Merrimack Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Nielsen Ulrik B.
Merrimack Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer CROCKER GARY L
Merrimack Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Andersen Eric
Merrimack Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Andersen Eric
Merrimack Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(0%),Point72 Capital Advisors, Inc.(0%), etc.
No Data